Biogen completes acquisition of RayThera in immunology push
Biogen Inc. (Nasdaq: BIIB) announced the completion of its acquisition of RayThera Inc., a privately held biotechnology company focused on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
